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Abstract
Background: Members of the ZFP36 family of RNA-binding proteins regulate gene expression post-transcriptionally
by binding to AU-rich elements in the 3’UTR of mRNA and stimulating mRNA degradation. The proteins within this
family target different transcripts in different tissues. In particular, ZFP36 targets myogenic transcripts and may have
a role in adult muscle stem cell quiescence. Our study examined the requirement of ZFP36L1 and ZFP36L2 in adult
muscle cell fate regulation.
Methods: We generated single and double conditional knockout mice in which Zfp36l1 and/or Zfp36l2 were deleted
in Pax7-expressing cells. Immunostained muscle sections were used to analyse resting skeletal muscle, and a
cardiotoxin-induced injury model was used to determine the regenerative capacity of muscle.
Results: We show that ZFP36L1 and ZFP36L2 proteins are expressed in satellite cells. Mice lacking the two
proteins in Pax7-expressing cells have reduced body weight and have reduced skeletal muscle mass.
Furthermore, the number of satellite cells is reduced in adult skeletal muscle and the capacity of this muscle
to regenerate following muscle injury is diminished.
Conclusion: ZFP36L1 and ZFP36L2 act redundantly in myogenesis. These findings add further intricacy to the
regulation of the cell fate of Pax7-expressing cells in skeletal muscle by RNA-binding proteins.
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Background
Paired box transcription factors 3 and 7 (Pax3 and Pax7,
respectively) are co-expressed in the dermomyotome
during mouse embryonic development [1, 2]. Their ex-
pression gives rise to myogenic progenitor cells which
are necessary for myogenic development. As critical reg-
ulators, Pax3 is required for embryonic myogenesis,
whilst Pax7 is predominantly required for adult myogen-
esis and specifies the adult stem cell population in
muscle [3–5]. The identity of the cells that arise from
the myogenic progenitor cells during embryonic and
adult myogenesis may be determined by the expression
of myogenic regulatory factors (MRFs) that are
expressed downstream of Pax3 and Pax7. In adult
skeletal muscle, satellite cells express Pax7 and they are
the adult stem cell population [5]. They largely reside in
a mitotically quiescent state between the basal lamina
and plasma membrane of myofibres [6, 7]. Typically, in
response to growth cues, tissue injury or disease, signals
from the surrounding environment, and from within the
specialised stem cell niche, promote exit from the quies-
cent state and induce satellite cell activation [8–11].
Following activation, satellite cells proliferate and either
enter the myogenic differentiation programme or
self-renew to re-establish the quiescent satellite cell pool
[8–10]. Knowledge of the mechanisms that maintain
adult stem cells within tissues in an undifferentiated
state, and control the differentiation or self-renewal fate
of these cells, is important for understanding tissue
homeostasis and may have application in the emerging
field of regenerative medicine.
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Genetic programmes act transcriptionally and post-
transcriptionally to achieve stringent regulation of the
development, specificity and replenishment of skeletal
muscle. At the level of transcription, MRFs bind to
the promoters of myogenic determination genes to
initiate gene expression and thus govern the transi-
tion from the muscle precursor cell or satellite cell to
multinucleated myofibre throughout development [12,
13]. Post-transcriptional regulation by alternative spli-
cing and polyadenylation, or by control of mRNA
translation and degradation, also regulates gene ex-
pression in satellite cells. Specifically, the interaction
between cis-acting elements within the mRNA and
trans-acting elements, such as microRNAs and
RNA-binding proteins (RBPs), regulates transcript sta-
bility and translation. There is accumulating evidence
to demonstrate that RBPs are necessary for normal
muscle physiology [14, 15]. In particular, RBPs includ-
ing HuR, AUF1, ZFP36 and KSRP bind to AU-rich el-
ements to modulate the expression of numerous
myogenic regulatory factors that function at different
phases of myogenesis to ensure normal skeletal
muscle development. The overlapping roles of these
RBPs indicate that the coordination between RBPs is
necessary for the normal progression of myogenesis
[16, 17]. Collectively, this highlights the importance
of RBPs in establishing cell identity during the normal
myogenic process.
Zfp36 encodes tristetraprolin (TTP) the prototype of a
small family of RBPs, called the ZFP36 family, that are
characterised by highly conserved tandem CCCH
zinc-finger RNA-binding domains [18]. ZFP36 is a RBP
that promotes RNA decay and negatively regulates the
expression of the myogenic regulatory factor MyoD by
binding to the 3’UTR of MyoD mRNA [1]. Mouse satel-
lite cells from Zfp36-deficient mice express increased
amounts of MyoD and display impaired satellite activa-
tion, demonstrating a role for ZFP36 in the maintenance
of quiescence [1]. The functions of the ZFP36L1 and
ZFP36L2 family members have not been evaluated in
skeletal muscle stem cell fate, but have been shown to
act redundantly to promote quiescence during lympho-
cyte development [19–21]. ZFP36L1 has been implicated
in the persistence of the marginal zone B lymphocyte
population [22] and ZFP36L2 in the maintenance of the
haematopoietic stem cell pool [23]. To date, the roles of
ZFP36L1 and ZFP36L2 in specific myogenic cell popula-
tions have not been studied. Here, we demonstrate that
loss of both ZFP36L1 and ZFP36L2 in Pax7-expressing
cells results in a reduced number of satellite cells in
adult mice, and furthermore, provide evidence that these
genes promote regeneration following muscle injury.
Mechanistically, we suggest that ZFP36L1 and ZFP36L2
may act redundantly in determining the cell fate of
Pax7-expressing cells during the normal myogenic
process, and we provide additional insight into the com-




Mice were bred and maintained in the Babraham Insti-
tute Biological Support Unit under Specific Opportunis-
tic Pathogen Free (SOPF) conditions. After weaning,
mice were transferred to individually ventilated cages
with 1–5 mice per cage. Mice were fed CRM (P) VP diet
(Special Diet Services) ad libitum and received environ-
mental enrichment. Mario Capecchi (University of Utah)
provided transgenic mice expressing Cre-recombinase
under the control of the Pax7 promoter (Pax7Cre) [24].
The Zfp36l1tm1.1Tnr and Zfp36l2tm1.1Tnr targeted condi-
tional alleles were generated at the Babraham Institute
[19]. Interbreeding generated mice on the C57BL/6
genetic background in which either or both floxed alleles
were present with Pax7Cre. For simplicity, these will be
referred to as Zfp36L1-P, Zfp36L2-P and Zfp36L1/L2-P
for Pax7CreZfp36l1fl/fl, Pax7CreZfp36l2fl/fl and Pax7-
Cre-Zfp36l1fl/flZfp36l2fl/fl, respectively. All experiments
were carried out without blinding or randomisation on
3–12-week-old mice.
Satellite cell isolation
Satellite cells were isolated from hind limb skeletal mus-
cles from mice using a protocol adapted from
Woodhouse et al. [25]. Briefly, 6–12-week-old mice were
sacrificed by rising CO2 and/or cervical dislocation
according to Schedule One of the Home Office Protocol
for the sacrifice of mice. Hind limb skeletal muscles
(including gastrocnemius, plantaris, soleus, tibialis anter-
ior (TA), extensor digitorum longus and quadriceps)
were dissected from the mice. To isolate individual cells,
the muscles were mechanically homogenised and further
digested in a DMEM solution containing 0.12% (w/v)
type II collagenase (Lorne Laboratories) and 2mg/ml
dispase II (Roche) at 37 °C with intermittent trituration
using a 19G needle during the incubation. To remove
excess debris, PBS was added and the slurry was passed
through a 40-μM filter. The filtrate was centrifuged at
1500×g, and the supernatant was discarded. Red blood
cells were lysed in a solution consisting of 140 mM
NH4Cl, 2 mM Tris-HCl at pH 7.2. Lysis was stopped by
addition of PBS. The remaining cells were extensively
washed, and non-specific antibody binding sites were
blocked with a PBS solution containing 2% foetal bovine
serum (PAA; PBS/FBS). Cells in PBS/FBS were incubated
with the following primary antibodies in the dark:
anti-CD31-PE (Abcam), anti-CD45-PE (BD Biosciences),
anti-Sca1-PE (BD Biosciences), anti-VCAM1-biotin (BD
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Biosciences) and anti-CD34-APC (eBioscience). The
VCAM1-biotin antibody was visualised by staining with
streptavidin-AlexaFluor488 conjugate (Life Technolo-
gies). Cells were finally stained with DAPI (2.5 μg/ml;
Life Technologies) and sorted using a BD FACSAria III
cell sorter (BD Bioscience). Antibodies against CD31,
CD45 and Sca-1 were used to gate the lineage-negative
cells. VCAM1- and CD34-positive satellite cells were
gated and collected into Eppendorf tubes containing a
high serum medium as described above. Satellite cells
were subsequently cultured or lysed for protein
extraction.
Primary satellite cell culture
Primary satellite cells were plated at a density of 1.5 × 104
per ml and cultured in a high serum medium containing
20% foetal bovine serum (PAA), 2 mM L-glutamine
(Invitrogen), 2 ml antibiotic anti-mycotic solution
(Promega) and 2.5 ng/ml basic fibroblast growth factor
(Promega) in DMEM (Invitrogen). All cells were main-
tained using standard tissue culture techniques at 37 °C in
5% CO2 at a relative humidity of 100%.
Muscle regeneration model
Muscle injury and regeneration was characterised in 6–
12-week-old mice using cardiotoxin (CTX; Sigma-Aldrich).
Mice were anaesthesised with isofluorane according to
standard protocols. Ten micromolar CTX was pre-
pared in PBS and 100 μl was injected into the TA
muscle of isofluorane-anaesthetised mice. To act as
an internal vehicle control, 100 μl of PBS was injected
into the contralateral TA. Following the procedure,
mice were housed and cared for as described above.
Mice were sacrificed 1, 5, 10 and 25 days following
injury by rising CO2 and/or cervical dislocation ac-
cording to Schedule One of the Home Office Protocol
for the sacrifice of mice and the TA muscles were
harvested.
Histology
Mice were sacrificed as described above and the TA was
dissected from the ventral crest of the tibia and mounted
vertically with the largest part of the TA on the base of a
cork disc (Fischer). The proximal tendons of the TA
were used to balance the TA upright against a needle to
enable transverse cross-sectioning. The TA was coated
in Tissue Tek (Leica) and snap frozen in liquid
nitrogen-cooled iso-pentane (VWR). Transverse
cross-sections (10 μm) were generated on a Leica Cryo-
stat (Leica) and collected on pre-treated positively-
charged glass microscope slides (VWR). Transverse
cross-sections of the TA were stained with filtered Gill’s
haematoxylin solution (Sigma-Aldrich) and eosin
(VWR) to analyse tissue morphology, or Weigert’s
haematoxylin (TCS Biosciences) and Van Gieson solu-
tion (Sigma-Aldrich) to analyse fibrosis, according to
standard protocols. Sections were dehydrated in etha-
nol, immersed in xylene (VWR), mounted with a glass
coverslip in Entellen (Merck) and air-dried under a
laminar flow cupboard.
Immunofluorescence of cryosections
TA cryosections on glass slides were fixed and per-
meabilised. Non-specific binding sites were blocked
with an IgG blocking reagent (M.O.M; Vector Labora-
tories) and subsequently with a PBS solution contain-
ing 3% BSA, 5% goat serum and 0.2% (w/v) Triton
X-100 (blocking buffer). The following primary anti-
bodies were prepared in the blocking buffer and incu-
bated overnight at 4 °C: anti-Pax7 (DSHB), anti-MyoD
(Santa Cruz), anti-Myogenin (Santa Cruz) and
anti-laminin α-2 chain (Enzo Life Sciences). Sections
were incubated in the dark at room temperature with
the fluorescence-conjugated secondary antibodies
AlexaFluor 488 (donkey anti-rabbit; Life Technolo-
gies), AlexaFluor 568 (goat anti-mouse; Life Technolo-
gies) and/or AlexaFluor 633 (goat anti-rat; Life
Technologies) in blocking buffer. Sections were
washed in PBS/TX. To stain the nuclei, DAPI was di-
luted in PBS/TX and incubated with the sections in
the dark at room temperature. The sections were
washed in PBS/TX and then mounted with glass cov-
erslips using Vectashield, a hard set mounting
medium (Vector Laboratories). Slides were dried in
the dark at room temperature.
Western blotting
Proteins were extracted and Western blotting was per-
formed as described in [26]. The following primary anti-
body dilutions were prepared in a PBS solution (0.1M
phosphate buffer was used throughout) containing 0.2%
I-Block (Applied Biosystems) and 0.05% Tween-20:
anti-BRF1/2 (Cell Signalling Technologies), anti-pan
ZFP36-family (SB1/30.13) and anti-β-actin (Abcam). The
following secondary antibodies were diluted in a PBS so-
lution containing 0.05% Tween-20: goat anti-rabbit-HRP
conjugated (Biorad) or donkey anti-rat-HRP conjugated
(Abcam).
Statistical analysis and imaging
The statistical tests used are indicated in the figure
legends. A minimum of three replicates were per-
formed for each experiment, and data are presented
as means ± SEM. All images were acquired using a ×
40 objective lens on an Olympus confocal microscope,
and quantification was performed using ImageJ soft-
ware (NIH).
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Results and discussion
The role of RNA-binding proteins in controlling cell fate
is emerging as an important mechanism. In mice, the
transcripts encoding the three ZFP36 family members
are expressed in the skeletal muscle system and, more
specifically, are expressed to varying degrees in quiescent
and activated satellite cells [1]. By the Western blotting
of proteins from isolated satellite cells from mouse adult
skeletal muscle, we found that both ZFP36L1 and
ZFP36L2 are expressed in this myogenic cell population
(Fig. 1a; the results of a second independent experiments
are shown in Additional file 1). Germline knockout mice
for Zfp36l1 and Zfp36l2 exhibit severe developmental
and growth defects and as a result Zfp36l1 knockout
mice die in utero between E8 and E12 and Zfp36l2
knockout mice die within 2 weeks of birth [23, 27–29].
Therefore, we adopted a conditional tissue-specific
knockout approach and used Pax7Cre to delete Zfp36l1
and/or Zfp36l2 in Pax7-expressing cells. In mice, skeletal
muscle progenitor cells arise in the dermomyotome dur-
ing E9 and E12 of embryonic development, and specific-
ally, Pax7 is first expressed in muscle progenitor cells in
the central regions of the dermomyotome at around E10
[2, 4, 30, 31]. In our model, Zfp36l1 and/or Zfp36l2
would therefore be deleted in Pax7-expressing progeni-
tor cells during the development of the dermomyotome,
as well as in Pax7-expressing cells in adults.
Mice with targeted mutation of either RBP in their
Pax7-expressing cells were viable and did not display
any whole body growth or muscle mass defects (Add-
itional file 2). Thus, the expression and activity of
Pax7Cre, or the loss of Zfp36l1 or Zfp36l2, do not pre-
vent mouse development or affect whole body growth.
Mice lacking both Zfp36l1 and Zfp36l2 in
Pax7-expressing cells (hereafter called Zfp36L1/L2-P)
were viable, but were severely growth-retarded com-
pared to Cre-negative littermates (hereafter called con-
trol; Fig. 1b). Whole body growth retardation was
apparent from 3 weeks of age and continued to adult-
hood in both male and female mice (Fig. 1b). Further-
more, both the TA and gastrocnemius muscles from
Zfp36L1/L2-P mice were significantly reduced in weight
compared to the same muscles from the control mice.
Satellite cells isolated from Zfp36L1/L2-P adult mice
contained no detectable ZFP36L1 or ZFP36L2 protein
indicating effective ablation of both proteins (Fig. 1a and
Additional file 1). However, further examination of the
embryonic developmental stages from when Pax7 is first
expressed is required to determine when precisely the
Zfp36l1 and Zfp36l2 genes are deleted and any effects of
this on the developing embryo. We did not establish
whether ZFP36 was expressed in the isolated satellite
cells from Zfp36L1/L2-P mice, but at the genetic level it
was unable to compensate for the loss of Zfp36l1 and
Zfp36l2, and support whole body and skeletal muscle
growth.
Transverse cross sections of the TA from Zfp36L1/
L2-P mice stained with haemotoxylin and eosin (H and
E), and immunostained with anti-laminin, indicated that
the myofibre organisation and architecture were similar
to controls, and although this was not quantified, we ob-
served a mixture of small and large myofibres (Fig. 1d).
Furthermore, all nuclei were peripheral and located
around the myofibres, and similarly to controls, there
was no apparent on-going muscle degeneration or re-
generation. Quantification of myofibre size and the dis-
tribution of myofibre types may provide further
understanding of the roles of ZFP36L1 and ZFP36L2 on
adult skeletal muscle architecture. Taken together, these
data are consistent with a requirement for Zfp36l1 and
Zfp36l2 to promote whole body growth and sustain skel-
etal muscle development in adults. Studies have demon-
strated that Pax7-expressing cells contribute little to
embryonic development, but show that Pax7 expression
is required for adult myogenesis and specification of sat-
ellite cells [3, 5, 32]. Further work is required to deter-
mine whether the observed phenotypes are due to
defects in the Pax7 cell population at earlier develop-
mental stages.
In adults, studies suggest that a decrease in myofi-
bre volume may be related to a decline in nuclei
number and more specifically a decrease in satellite
cells, which could delay myonuclei turnover [33]. As
satellite cells are required for post-natal growth, we
explored this possibility by assessing whether Zfp36l1
and Zfp36l2 could regulate the satellite cell popula-
tion. Transverse cross sections of the TA muscle
were immunostained with anti-Pax7 and were used
to quantify the number of satellite cells per field of
view (Fig. 2 and Additional file 2). Quantifying and
investigating satellite cell fate decisions on single
myofibres is a well-established and useful method of
analysing a range of satellite cell dynamics [34–36].
However, it was not possible to determine the num-
ber of satellite cells or to examine satellite cell fate
in single myofibres isolated from Zfp36L1/L2-P mice.
In our experiments, we found that Zfp36L1/L2-P
myofibres could not be successfully cultured and sat-
ellite cells seemed to ‘wash away’. This could be in-
dicative of an intrinsic inability of satellite cells from
Zfp36L1/L2-P mice to associate with the myofibre
under these conditions. Further work is needed to
investigate this more thoroughly.
The deletion of Zfp36l1 alone in Pax7-expressing cells
did not result in a change in satellite cell number in TA
cross sections, and deletion of Zfp36l2 had little, if any,
effect on the number of satellite cells (Additional file 2).
Due to the whole body growth difference in the
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Zfp36L1/L2-P mice, the number of satellite cells was
quantified at two post-natal developmental time points
to determine if there was a change in the number of sat-
ellite cells with age. At both 3 and 7 weeks of age, the
number of satellite cells per field of view was signifi-
cantly decreased in TAs from the Zfp36L1/L2-P mice
compared to controls (Fig. 2). Whilst we only focused
on the adult population of Pax7-expressing cells, it is
feasible that reduced muscle mass and reduced satellite
cell number in adult skeletal muscle may be due to de-
fects and depletion of the Pax7-expressing cell pool early
in embryonic development. Nevertheless, we conclude
Fig. 1 ZFP36L1 and ZFP36L2 are both required for whole body growth. Characterisation of Zfp36L1/L2-P mice. Controls represent Cre-negative
littermates. a Western blot showing the ablation of ZFP36L1 and ZFP36L2 in isolated satellite cells from Zfp36L1/L2 mice (see also Additional file 1).
b Weights of male and female Zfp36L1/L2-P and control mice measured from 10 days to 45 days of age. Error bars represent SEM, p < 0.0001****
measured by two-way ANOVA with Tukey’s multiple comparison test, n = 10. c Weights of tibialis anterior (TA) and gastrocnemius hind limb skeletal
muscle from 3- to 4-week-old Zfp36L1/L2-P and control mice in milligrammes. Significance was measured by unpaired, two-tailed Mann Whitney test,
n = 8 for control; n = 7 for Zfp36L1/L2-P. d Transverse cross sections of TA muscles were stained with haematoxylin (H; myofibre; pink) and eosin (E;
nuclei; purple), and immunostained with antibodies against laminin (green), an extracellular matrix protein to delineate the periphery of the individual
muscle fibres and with DAPI (blue), a nuclear marker. Scale bars: 100 μm. H and E images were acquired using a × 20 objective lens, and
immunofluorescence images were acquired using a × 40 objective lens. Images representative of n = 3
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that ZFP36L1 and ZFP36L2 are not absolutely required
to establish skeletal muscle and suggest that these RBPs
may have a role in Pax7-expressing cells in adult skeletal
muscle. Further work is required to establish the myo-
genic potential of the mutant Pax7-expressing cells at all
stages of development. The requirement for Zfp36l1 and
Zfp36l2 in satellite cell function is unresolved. The data
suggest there is a redundant requirement for Zfp36l1
and Zfp36l2 for the expansion of progenitor cells and/or
for the progression through the myogenic programme.
Redundancy between Zfp36l1 and Zfp36l2 has been
demonstrated in the development of lymphocytes
[19–21]. ZFP36L1 and ZFP36L2 both contain two highly
conserved zinc finger domains with similar RNA-binding
properties [18]. Their homology and presumably similar
mRNA-binding specificities provide the simplest explan-
ation for the observed redundancy, but this requires
formal demonstration.
Fig. 2 Deleting ZFP36L1 and ZFP36L2 in Pax7-expressing cells reduces the number of satellite cells in TA muscles. Transverse cross sections from
3- to 4-week-old Zfp36L1/L2-P and control mice. Controls represent Cre-negative littermates. a Sections were immunostained with antibodies
against Pax7 (red), a marker of adult satellite cells, laminin (green), an extracellular matrix protein to delineate the periphery of the individual
muscle fibres, and with DAPI (blue), a nuclear marker. Open arrows indicate Pax7+ cells. Scale bars: 100 μm. b Average number of
satellite cells in TAs from control and Zfp36L1/L2-P mice. Error bars represent SEM, significance measured by unpaired two-tailed Student’s
t test, n = 3. Calculations from 10 fields of view per experiment
Bye-A-Jee et al. Skeletal Muscle            (2018) 8:37 Page 6 of 12
In addition to a requirement for post-natal growth,
satellite cells also have a role in muscle regeneration
following injury [25, 37–40]. To examine the regen-
erative capacity of skeletal muscle from Zfp36L1/L2-P
mice, 6–12-week-old mice were challenged with cardi-
otoxin (CTX), an agent that induces muscle degener-
ation, but leaves satellite cells intact (Fig. 3 and
Additional file 3). CTX was administered locally into
the TA muscle, and a PBS “vehicle control” was ad-
ministered into the contralateral muscle. Muscles
were recovered at 1, 5, 10, or 25 days following treat-
ment, and transverse cross sections were stained with
H and E to assess the extent of damage to the skel-
etal muscle architecture (Fig. 3a and Additional file 3),
and Van Gieson’s stain, which stains collagen and is
an indicator of fibrosis (Fig. 3b). TA muscles from
both mutant and control mice that had been injected
with the vehicle control did not exhibit any injury
and there was no visible change in myofibre arrange-
ment or obvious fibrosis throughout the injury time
course (Fig. 3 and Additional file 3). TAs injected
with the vehicle control was thus valid uninjured con-
trols. H and E staining of CTX-injured TAs from
mice lacking either Zfp36l1 or Zfp36l2 in Pax7-ex-
pressing cells was indistinguishable from controls
(Additional file 3).
TAs from control and Zfp36L1/L2-P mice injected
with CTX demonstrated striking morphological
changes characterised by myofibre degeneration and
an increased number of nuclei, indicative of infiltrat-
ing leukocytes and fibrosis (Fig. 3). Typically, in the
injured control TAs at 1 day post-injury, myofibres
dissociated from their regular arrangement; at 5 and
10 days post-injury, there was further myofibre
disruption and increased leukocyte infiltration (in-
ferred from the staining of nuclei) as the muscle
Fig. 3 Deleting ZFP36L1 and ZFP36L2 in Pax7-expressing cells impairs skeletal muscle regeneration. The TA muscles of Zfp36L1/L2-P mice were
injected with either CTX or PBS. Muscles were harvested at 1, 5, 10 or 25 days following treatment and transverse cross sections were generated.
Controls represent Cre-negative littermates. a Sections were stained with haematoxylin (H; myofibre; pink) and eosin (E; nuclei; purple) to assess
the skeletal muscle architecture. Open arrows identify centrally located nuclei, an indication of muscle regeneration. b Sections were Van Gieson’s
stain to determine the extent of fibrosis. Closed arrows indicate fibrotic tissue (red). Insets of respective PBS-injected, uninjured contralateral TA
muscles are in the left-hand corner of each image. Scale bars: 100 μm. Images representative of n = 3 at each time point
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degenerated; and at 25 days post-injury, myofibre re-
generation was apparent by the presence of myofi-
bres that harboured nuclei, which were centrally
located, and fewer nuclei of infiltrating cells (Fig. 3).
TAs from Zfp36L1/L2-P mice at day 1 following
muscle injury, appeared similar to injured TAs from
control mice. At 5 and 10 days post-injury, muscle
regeneration appeared delayed and there was in-
creased collagen staining in between myofibres com-
pared to controls (Fig. 3b). At 25 days post-injury,
there were centrally located nuclei within myofibres,
indicating regeneration. However, this regeneration
appeared to be reduced in comparison to control
TAs (Fig. 3a). As we deleted ZFP36L1 and ZFP36L2
in Pax7-expressing cells, it is possible that the
impaired regeneration may be due to defects in the
function of myogenic cells derived from Pax7-expressing
progenitor cells.
To investigate the requirement for Zfp36l1 and
Zfp36l2 further, transverse cross sections from injured
control and Zfp36L1/L2-P were immunostained with
antibodies against myogenin (Fig. 4a), which is required
for myoblasts to differentiate further into myofibres. In
injured TAs from control and Zfp36L1/L2-P mice, there
was a peak in the number of myogenin+ cells at the 5
day time point (Fig. 4b). At the 10 and 25 day time
points, the numbers of myogenin+ cells in the injured
TAs from Zfp36L1/L2-P mice were similar to those in
the injured control TAs (Fig. 4b). Whilst we are unable
to exclude the possibility that a difference might have
Fig. 4 Terminal differentiation can occur independently of ZFP36L1 and ZFP36L2. Transverse cross sections of injured TAs from Zfp36L1/L2-P
mice were immunostained with antibodies for Pax7 (red), myogenin (myog; turquoise), laminin (lam; green), and counterstained with the nuclear
marker DAPI (blue). Controls represent Cre-negative littermates. a Representative images of injured control and Zfp36L1/L2-P TAs. Insets
represent PBS-injected, uninjured contralateral TA muscles. Open arrows indicate myogenin+ myogenic cells (myog; turquoise). Scale bars:
100 μm. b Average number of myogenin+ cells present in injured control and Zfp36L1/L2-P TAs during the injury time course. Images were acquired
using a × 40 objective lens. Calculations were based on 10 fields of view per experiment. Error bars represent the SEM, two-way ANOVA adjusted for
multiple comparisons with Sidak’s post hoc test, n = 3
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Fig. 5 (See legend on next page.)
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been found with a larger sample size, there was little
effect, if any, of the deletion of Zfp36l1 and Zfp36l2 on
terminal differentiation at day 5. We show that muscle
from Zfp36L1/L2-P mice has a diminished regenerative
capacity and suggest that this may reflect the reduced
availability or function of satellite cells.
To assess the satellite cell population, CTX-injured
TAs were stained during the injury time course with
anti-Pax7 to identify quiescent satellite cells and
self-renewed satellite cells, and anti-MyoD to identify
muscle lineage committed cells (myoblasts). Cells
co-staining with anti-Pax7 and anti-MyoD were
considered to be activated (Pax7+MyoD+) satellite
cells (Fig. 5a). At each time point, we quantified the
number of Pax7+, MyoD+ and Pax7+MyoD+ cells in
sections from injured and uninjured TAs in control
and Zfp36L1/L2-P mice. In the TAs from control
mice at days 5 and 10 post-injury, the Pax7+ satellite
cell pool expanded (Fig. 5b), the number of activated
(Pax7+MyoD+) satellite cells increased (Fig. 5c), and
there was an increased number of MyoD+ cells (Fig. 5d).
At 25 days post-injury, the number of Pax7+ satellite
cells returned to uninjured levels and the number of
activated (Pax7+MyoD+) satellite cells and MyoD+
cells reduced to nearly that of uninjured TAs. This
suggests the return of satellite cells to quiescence and
almost complete regeneration (Fig. 5b). By contrast,
in injured TAs from Zfp36L1/L2-P mice, the pool of
Pax7+ satellite cells did not expand, and there were
negligible numbers of activated (Pax7+MyoD+) satellite
cells (Fig. 5b, c). There was an increase in the number of
MyoD+ cells at the 5 day post-injury time point (Fig. 5d).
This increase in MyoD+ cells may contribute to the
capacity of injured TAs from Zfp36L1/L2-P mice to
undergo regeneration.
In our model, Zfp36l1 and Zfp36l2 are deleted in
Pax7-expressing cells throughout development; thus,
we can not rule out the possibility that the regenera-
tive defect could be as a result of a requirement for
the RBPs in Pax7-expressing cells in the dermomyo-
tome and/or Pax7-derived myogenic cells. Here, we
used the Pax7Cre mouse line to address roles for
ZFP36L1 and ZFP36L2 in myogenesis. In future, the
utilisation of genetic tools which permit elective dele-
tion of Zfp36l1 and Zfp36l2 in Pax7-expressing cells
[41, 42] would offer an opportunity to clearly define
the functional properties of the adult satellite cell
population independently of developmental effects.
Furthermore, the measurement of mRNA abundance
could reveal the effect these proteins have on gene
expression and allow for mechanisms of action to be
ascertained. We did not establish mRNA targets for
ZFP36L1 and ZFP36L2 in our system. Interestingly, the
closely related ZFP36 RBP has been shown to regulate the
expression of MyoD mRNA [1], and it is feasible that
ZFP36L1 and ZFP36L2 also regulate MyoD expression in
myogenic cells. The application of methods that measure
RNA-protein interactions in intact cells [43] could be
optimised and applied to satellite cells and their myogenic
derivatives from adults to identify the direct targets and
thereby develop the understanding of gene regulation by
RBPs in skeletal muscle.
Conclusions
We show that Zfp36l1 and Zfp36l2 act redundantly to
determine the number of functional Pax7-expressing
cells in adult mice. The lack of a phenotypic effect of the
targeting by Pax7cre of Zfp36l1 or Zfp36l2 alone on
skeletal muscle argues against the phenotypes being due
to the non-specific effects of cre. The requirement for
Zfp36l1 or Zfp36l2 in Pax7-expressing cells is important
for the growth and regenerative capacity of adult skeletal
muscle. The mechanisms by which these RBPs regulate
the function and fate of Pax7-expressing cells remains to
be established, but in other systems, these RBP regulate
quiescence [20] and cellular identity [22, 44]. Our find-
ings should prompt further experiments designed to
understand how ZFP36L1 and ZFP36L2 control cell fate
decisions and the kinetics of cell turnover.
Additional files
Additional file 1: Confirmation of ablation of ZFP36L1 and ZFP36L2 in
satellite cells of Zfp36L1/L2-P mice. Western blot determining the expression
of ZFP36L1 and ZFP36L2 in isolated satellite cells from Zfp36L1/L2-P and
control mice. (TIF 76 kb)
(See figure on previous page.)
Fig. 5 Deleting ZFP36L1 and ZFP36L2 in Pax7-expressing cells impairs expansion of the satellite cell pool during skeletal muscle regeneration.
Transverse cross sections of injured TAs from Zfp36L1/L2-P mice were immunostained with antibodies for Pax7 (red), MyoD (turquoise), Laminin
(lam; green), and counterstained with the nuclear marker DAPI (blue). Activated cells were co-stained with Pax7 and MyoD (white). Controls represent
Cre-negative littermates. a Representative images of injured control and Zfp36L1/L2-P TAs. Insets represent PBS-injected, uninjured contralateral TA
muscles. Open arrows indicate Pax7+ satellite cells (red); closed arrows indicate MyoD+ myogenic cells (turquoise), and dotted arrows indicate Pax7
+MyoD+ activated satellite cells (white). Scale bars: 100 μm. b Average number of satellite cells present in injured control and Zfp36L1/L2-P TAs during
the injury time course. c Average number of activated cells present in injured control and Zfp36L1/L2-P TAs during the injury time course. d Average
number of MyoD+ cells present in injured control and Zfp36L1/L2-P TAs during the injury time course. Images were acquired using a × 40 objective lens.
Calculations from 10 fields of view per experiment. Error bars represent the SEM, two-way ANOVA adjusted for multiple comparisons with Sidak’s post hoc
test, n = 3
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Additional file 2: Characterisation of mice lacking either Zfp36l1 or Zfp36l2
(referred to as Zfp36L1-P or Zfp36L2-P mice). A. Weights of male and female
mice measured from 10 to 45 days. Error bars represent SEM, two-
way ANOVA with Tukey’s multiple comparison test, n = 10. B. TA
and gastrocnemius muscle weights from 7-week-old male and female mice.
Significance was measured by unpaired two-tailed Mann Whitney test; n = 6
for Zfp36L1-P and its respective control, and n = 8 for Zfp36L2-P and
its control. Red data points indicate female mice and blue data points indicate
male mice for the Zfp36L2-P graph. C. Average number of satellite cells in
cross-sections of TAs from 7-week-old control, Zfp36L1-P and Zfp36L2-P mice.
Error bars represent SEM, significance was measured by unpaired two-tailed
Student’s t test; n = 5 for Zfp36L1-P and its respective control, and n = 4 for
Zfp36L2-P and its control. Controls represent Cre-negative littermates. Calculations
based on 10 fields of view per experiment. (TIF 201 kb)
Additional file 3: Transverse cross sections of the TA muscles from mice
lacking either Zfp36l1 or Zfp36l2 (referred to as Zfp36L1-P or Zfp36L2-P
mice), and their respective controls, recovered at 1, 5, 10 and 25 days
following injection with either CTX or PBS, stained with haematoxylin
(H; myofibre; pink) and eosin (E; nuclei; purple) to assess the skeletal
muscle architecture. Open arrows identify centrally located nuclei, an
indication of muscle regeneration. Controls represent Cre-negative littermates.
Scale bars: 100 μm. Representative of n = 3. (TIF 843 kb)
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